NorthWest Biotherapeutics Inc (NWBO)

[ccie1024]

“Where did this come from?
survived the longest (11% at 30 months).”

rGBM I suspect.

“For 64 patients with rGBM receiving DCVax-L, mOS was 13.2 (95% CI, 9.7-16.8) months from relapse vs 7.8 (95% CI, 7.2-8.2) months among control patients (HR, 0.58; 98% CI, 0.00-0.76; P?
If you want to suggest that is correct and misleading at the same time, I won’t disagree.

“…13% at 60 months…” just sounds too good anyway, I’m sure that’s why the authors omitted that bit.